Adverse effects of medications on urinary symptoms and flow rate: A community-based study
| Autor: | Ling Su, Michael M. Lieber, Laurel A. Panser, Cynthia J. Girman, Steven J. Jacobsen, Harry A. Guess, Joseph E. Oesterling |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Adult
Male medicine.medical_specialty Epidemiology Cross-sectional study Health Status Minnesota Urination Cohort Studies Surveys and Questionnaires Internal medicine medicine Humans Urinary Tract Adverse effect Aged business.industry Urination disorder Guideline Middle Aged Antidepressive Agents Confidence interval Bronchodilator Agents Surgery Cross-Sectional Studies Socioeconomic Factors Histamine H1 Antagonists Anxiety medicine.symptom business Cohort study |
| Zdroj: | Journal of Clinical Epidemiology. 49:483-487 |
| ISSN: | 0895-4356 |
| Popis: | The relationship between urinary symptoms and medication use was investigated in a community-based cross-sectional study involving a random sample of 2115 men 40-79 years of age in Olmsted County, Minnesota. The American Urological Association Symptom Index (AUASI) was generated from a validated self-administered questionnaire. Medication use was assessed by in-person interviews. While 1087 men reported daily medication use, only 136 reported daily use of medications known to affect urinary function adversely, including antidepressants (42), antihistamines (23), and bronchodilators (43). Age-adjusted AUASI scores were higher in men reporting daily use of antidepressants, and the association persisted after additionally adjusting for the Depression and Anxiety subscales of the General Psychological Well-Being Scale (adjusted mean difference, 2.1; 95% confidence interval (CI), 0.5-3.6; p = 0.008). The adjusted AUASI was also higher among men who took antihistamines daily (adjusted mean difference, 2.3; 95% CI, 0.3-4.3; p = 0.03). Lower age-adjusted urinary flow rates occurred with antidepressants, but not with antihistamines or bronchodilators. Clinicians evaluating men for causes of voiding dysfunction in accordance with the Agency for Health Care Policy and Research practice guideline for the diagnosis and management of benign prostatic hyperplasia should be aware that daily use of antidepressants or antihistamines may be associated with AUASI scores that are two to three points higher than in men not taking these medications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect